Home/Filings/4/0000818764-98-000003
4//SEC Filing

CENTEX DEVELOPMENT CO LP 4

Accession 0000818764-98-000003

CIK 0000818764operating

Filed

Aug 24, 8:00 PM ET

Accepted

Size

8.9 KB

Accession

0000818764-98-000003

Insider Transaction Report

Form 4
Period: 1998-07-31
Fresne, Donald C.
DirectorPresident and Chief Executive Officer
Transactions
  • Award

    Option Right to Buy

    1999-04-01+0.1510.151 total
    Exercise: $38.69
Footnotes (2)
  • [1]Exercisable: 1,800 shares of Centex Common Stock (.0272 Warrants to Purchase Class B Units) each on April 1, 1998, 1999, 2000, 2001 and 2002.
  • [2]Pursuant to a Nominee Agreement dated November 30, 1987, each person who is the beneficial owner of shares of Centex Corporation ("Centex") Common Stock is also the beneficial owner of an undivided interest in 900 warrants (the "Warrants") to purchase Class B units of limited partnership interest in Centex Development Company, L.P. ("CDC") at an exercise price of $500 per Class B unit, which Warrants are held of record by Chemical Bank as successor nominee. Each benefical owner's proportionate interest in the Warrants is equal to the number of shares of Centex Common Stock he owns divided by the total number of shares of Centex Common Stock outstanding from time to time. The exercise price for the Warrants will be determined at the time they become exercisable based on the number of Warrants that are then exercisable, the manner in which the Warrants are subdivided is at the discretion of the general partner of CDC and the humber of shares of Centex Common Stock outstanding at that time. The Warrants will be exercisable for a 90-day period commencing on a date to be extended by a vote of the Centex stockholders. Until the Nominee Agreement is terminated with respect to the Warrants and certificates evidencing the Warrants are issued in the name of the beneficial owners thereof, the Reporting Person has no right to obtain a certificate evidencing his beneficial interest in the Warrants or to dispose of the Warrants separate from Centex Common Stock. Computations set forth in this Form have been made using 59,555,506 shares of Centex Common Stock outstanding as reported in Centex Corporation's Form 10-K for fiscal quarter ending March 31, 1998.

Issuer

CENTEX DEVELOPMENT CO LP

CIK 0000818764

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000818764

Filing Metadata

Form type
4
Filed
Aug 24, 8:00 PM ET
Size
8.9 KB